Therese Liechtenstein
Therese Liechtenstein
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells
JJ Pen, BD Keersmaecker, C Heirman, J Corthals, T Liechtenstein, ...
Gene therapy 21 (3), 262-271, 2014
Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity
K Van der Jeught, PT Joe, L Bialkowski, C Heirman, L Daszkiewicz, ...
Oncotarget 5 (20), 10100, 2014
Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer
I Dufait, JK Schwarze, T Liechtenstein, W Leonard, H Jiang, D Escors, ...
Oncotarget 6 (14), 12369, 2015
A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice
T Liechtenstein, N Perez-Janices, M Gato, F Caliendo, G Kochan, ...
Oncotarget 5 (17), 7843, 2014
PD-L1/PD-1 co-stimulation, a brake for T cell activation and a T cell differentiation signal
T Liechtenstein, I Dufait, C Bricogne, A Lanna, J Pen, K Breckpot, ...
Journal of clinical & cellular immunology, 2012
Modulating co-stimulation during antigen presentation to enhance cancer immunotherapy
T Liechtenstein, I Dufait, A Lanna, K Breckpot, D Escors
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly …, 2012
Lentiviral vectors for cancer immunotherapy and clinical applications
T Liechtenstein, N Perez-Janices, D Escors
Cancers 5 (3), 815-837, 2013
A core of kinase-regulated interactomes defines the neoplastic MDSC lineage
M Gato-Cañas, XM de Morentin, I Blanco-Luquin, J Fernandez-Irigoyen, ...
Oncotarget 6 (29), 27160, 2015
Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of …
T Liechtenstein, N Perez-Janices, I Blanco-Luquin, C Goyvaerts, ...
Oncoimmunology 3 (7), e945378, 2014
Retroviral and lentiviral vectors for the induction of immunological tolerance
I Dufait, T Liechtenstein, A Lanna, C Bricogne, R Laranga, A Padella, ...
Scientifica 2012, 2012
Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?
D Escors, T Liechtenstein, N Perez-Janices, J Schwarze, I Dufait, ...
Oncoimmunology 2 (10), e26148, 2013
Immune modulation by genetic modification of dendritic cells with lentiviral vectors
T Liechtenstein, N Perez-Janices, C Bricogne, A Lanna, I Dufait, ...
Virus research 176 (1-2), 1-15, 2013
Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis
N Perez-Janices, I Blanco-Luquin, N Torrea, T Liechtenstein, D Escors, ...
Oncotarget 6 (27), 23944, 2015
Targeted lentiviral vectors: current applications and future potential
C Goyvaerts, T Liechtenstein, C Bricogne, D Escors, K Breckpot
Gene Therapy-Tools and Potential Applications, 2013
Lentiviral vectors in immunotherapy
I Dufait, T Liechtenstein, A Lanna, R Laranga, A Padella, C Bricogne, ...
Gene Therapy-Tools and Potential Applications, 2013
Inmunoterapia genética con células dendríticas para el tratamiento del cáncer
M Gato, T Liechtenstein, I Blanco-Luquín, MI Zudaire, G Kochan, D Escors
Anales del Sistema Sanitario de Navarra 38 (2), 279-287, 2015
Critical mass hypothesis of T-cell responses and its application for the treatment of T-cell lymphoma
C Bricogne, R Laranga, A Padella, I Dufait, T Liechtenstein, K Breckpot, ...
Hodgkin’s and T-cell lymphoma: Diagnosis, Treatment Options and Prognosis …, 2012
Manipulating immune regulatory pathways to enhance T cell stimulation
JJ Pen, JL Aerts, T Liechtenstein, D Escors, K Breckpot
Immune response activation, 2014
Lentivector-based cancer immunotherapy silencing PD-L1 and modulating cytokine priming; development of ex vivo myeloid-derived suppressor cells to assess therapeutic efficacy.
TM Liechtenstein
UCL (University College London), 2015
Modulating co-stimulation during antigen presentation to enhance cancer immunotherapy
T Liechtenstein, N Perez-Janices, K Breckpot, D Escors
Human Gene Therapy 24 (12), 166-166, 2013
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20